| Date | Description |
| 17 October 2008 | Schering-Plough Announces Transition of Animal Health LeadershipKENILWORTH, N.J., Oct. 17, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced the transition of leadership of its Animal Health unit from Ruurd Stolp, D.V.M., Ph.D., to Raul E. Kohan, who ... |
| 9 October 2008 | Intervet/Schering-Plough Animal Health extends its portfolio with LEVENTA® and supports veterinary endocrinologyBOXMEER (the Netherlands), October 9, 2008 – As the global leader in the field of veterinary endocrinology, Intervet/Schering-Plough Animal Health today announces a further extension to its portfolio ... |
| 15 September 2008 | Intervet/Schering-Plough Animal Health introduces Porcilis® COLI 6C swine vaccine against E. coli and Clostridium perfringensBOXMEER (the Netherlands), September 15, 2008 – Intervet/Schering-Plough Animal Health today announced the introduction of Porcilis® COLI 6C, a swine vaccine against E. coli and Clostridium perfringens. The ... |
| 10 September 2008 | Schering-Plough announces closing of planned divestiture of selected Animal Health products to PfizerKENILWORTH, N.J., September 10, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced the successful closing of its previously announced transaction with Pfizer Animal Health, to divest certain ... |
| 20 August 2008 | Intervet/Schering-Plough Animal Health shows innovative portfolio at WSAVA congress, Dublin - Hubert Trentesaux appointed as head of Global Companion AnimalBOXMEER (the Netherlands), August 20, 2008 – At the 33rd annual World Small Animal Veterinary Association Congress (WSAVA) in Dublin, Ireland, August 20-24, Intervet/Schering-Plough Animal Health, presents ... |
| 28 July 2008 | Intervet/Schering-Plough Animal Health Scholarship on Equine and Critical Care - First European Equine Emergency and Critical Care Scholarship launched in IrelandBOXMEER (the Netherlands), July 28, 2008 - A new scholarship on Equine Emergency and Critical Care has been started at a specialist equine hospital in County Kildare, at the heart of Ireland’s horse-racing ... |
| 7 July 2008 | Intervet/Schering-Plough Animal Health shows broad and innovative portfolio at World Buiatrics Congress - Edival Santos appointed as Head of Global CattleBOXMEER (the Netherlands), July 07, 2008 – At the 25th World Buiatrics Congress in Hungary, July 6-11, Intervet/Schering-Plough Animal Health, market leader in beef, dairy and small ruminants sectors, ... |
| 2 July 2008 | Schering-Plough announces closing of planned divestiture of selected Animal Health productsKENILWORTH, N.J., July 2, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced the successful closing of its previously announced transaction with Virbac, S.A. to divest animal health products ... |
| 28 May 2008 | Intervet/Schering-Plough Animal Health appoints Heads of Global Species teams for swine, poultry and aquacultureBOXMEER (the Netherlands), May 27, 2008 – Intervet/Schering-Plough Animal Health appointed the Heads of Global Species teams for the swine, the poultry and the aquaculture segment. These appointments ... |
| 27 - 29 May 2008 | Intervet/Schering-Plough Animal Health at VIV Europe in Moscow.Intervet / Schering Plough Animal Health at VIV Europe in Moscow.For the first time and before a large audience, Intervet / Schering Plough Animal Health will be presented as new combined company.In our ... |
| 19 May 2008 | Prof. Dr. George Gettinby honored with Dieter Lütticken AwardBOXMEER (the Netherlands), May 19, 2008 - At the 'World Aquaculture 2008”, held on May 19 -23 in Busan, Korea, Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom, was ... |
| 14 May 2008 | Intervet/Schering-Plough Animal Health formed worldwide region teams to support specific regional market needsBOXMEER (the Netherlands), May 14, 2008 – Intervet / Schering-Plough Animal Health has formed worldwide region teams that will support the market needs of the animal health business in these areas. Hugo ... |
| 8 May 2008 | Intervet/Schering-Plough Animal Health appoints Executive TeamBOXMEER (the Netherlands), May 08, 2008 – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments ... |
| 29 April 2008 | Intervet/Schering-Plough Animal Health outlines strength of the combination - First batch of bluetongue Bovilis BTV8 vaccine released to supply Northern European countriesBOXMEER (the Netherlands), April 29, 2008 – Intervet/Schering-Plough Animal Health released the first batch of Bovilis BTV8 vaccine against bluetongue to supply in Northern Europe. The animal health company, ... |
| 23 April 2008 | Schering-Plough announces planned divestiture of select animal health products in EuropeKENILWORTH, N.J., April 23, 2008 – Schering-Plough Corporation (NYSE: SGP) today announced two agreements to divest animal health products from 12 product franchises in Europe. These agreements are in ... |
| 17 March 2008 | Prof. Dr. George Gettinby wins Dieter Luetticken AwardBOXMEER (the Netherlands), March 17, 2008 – Intervet’s Dieter Lϋtticken Award has been granted to Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom. Gettinby’s innovative ... |
| 29 February 2008 | Intervet will supply French government with a minimum quantity of 27 million doses of Bluetongue vaccineANGERS (France), February 29, 2008 – Today, Intervet received an official order of the Department for Agriculture and Fishery, France, to supply inactivated vaccine against Bluetongue, serotype 8.Intervet ... |
| 27 February 2008 | Intervet takes the lead in veterinary endocrinology at NAVCORLANDO, FL, February 27, 2008 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet International, a part of Schering-Plough, ... |
| 19 January 2008 | Schering-Plough & Intervet together for better careORLANDO, FL, January 19, 2008 –Throughout its history, Schering-Plough has focused on discovering and developing innovative new therapies in the human prescription, animal health and consumer health customer ... |
| 16 January 2008 | Intervet has developed Bluetongue vaccineBOXMEER (the Netherlands), January 16, 2008 – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and ... |
| 20 November 2007 | INNOVAX™ successfully launched in the USINNOVAX™, the new innovative family of vaccines to aid in the prevention of very virulent Mareks Disease, Newcastle Disease and Infectious Laryngotracheitis (ILT), were launched successfully at the American ... |
| 10 October 2007 | Intervet wins award at ECVIM-CA congressIntervet wins an award for a scientific poster presentation on its new product Zitac® Vet during the annual congress of the ECVIM-CA. This year’s ECVIM-CA (European College of Veterinary Internal ... |
| 1 October 2007 | World Dairy Expo Dairyman of the Year, Industry Person of the Year Award Winners AnnouncedFrank Regan, Waukon, Iowa, Dairyman of the Year, Steve Larson, Fort Atkinson, Wisconsin, Industry Person of the YearThe winners of the 2007 World Dairy Expo Dairyman of the Year and Industry Person of ... |
| 24 August 2007 | Prof. Mark Stevens honored with Dieter Lütticken AwardBritish scientist awarded for excellent contribution to the principle of 3Rs for the development and production of veterinary medicinal productsBoxmeer, August 24, 2007 – At the '6th World Congress on ... |
| 1 August 2007 | Schering-Plough Animal Health Acquires International Distribution Rights for Aviguard® from MDLCompetitive-exclusion product controls intestinal disease in poultryLooking to expand its growing line of intestinal-health products for poultry, Schering-Plough Animal Health Corporation has acquired ... |
| 29 June 2007 | Intervet opens formulation and filling unit at its international competence center for Foot and Mouth DiseaseToday, Intervet, largest vaccine producer world wide, opens a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially ... |
| 22 June 2007 | Intervet Dieter Luetticken AwardIntervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicinesIntervet offers the Dieter Lütticken award to promote scientists or life science ... |
| 11 May 2007 | Intervet's bird flu vaccine receives EU licenseIntervet, a leading animal health company, received approval for its bird flu (avian influenza) vaccine Nobilis® Influenza H7N1. As a result, Europe now has a licensed vaccine to protect birds against ... |
| 3 May 2007 | Dieter Luetticken Award WinnerThe annual Dieter Lütticken Award, has been granted to Dr Mark Stevens from the Institute of Animal Health, United Kingdom for his commitment to advancing the 3R concept – reducing, refining or replacing ... |
| 16 April 2007 | New AQUAFLOR®-CA1 Conditionally Approved by FDA for Controlling Columnaris in CatfishFirst and only catfish antibiotic approved for highly prevalent and costly bacterial diseaseSchering-Plough Animal Health Corporation has introduced AQUAFLOR®-CA1 (florfenicol), the first and only in-feed ... |
| 21 March 2007 | AQUAFLOR® (florfenicol) Approved for Freshwater-reared SalmonidsFirst and only antibiotic in U.S. for coldwater diseaseAQUAFLOR® (florfenicol), the first new in-feed antibiotic licensed for U.S. aquaculture in more than two decades, has become the first and only antibiotic ... |
| 29 January 2007 | Intervet opens new production facility for vaccinesIntervet, the world’s largest producer of vaccines for animals, will open a production facility for vaccines in Boxmeer, the Netherlands, today. This will strengthen Boxmeer’s position as Intervet’s largest ... |
| 15 November 2006 | Intervet appoints Jochen Bader Vice President Finance and ControlIntervet, the animal health business unit of Akzo Nobel, appointed the current Director Finance and Control, Jochen Bader (46), Vice President Finance and Control. After graduating from ‘Fachhochschule’ ... |
| 15 November 2006 | Intervet appoints Malte Greune as a member of the company's Executive CommitteeIntervet, Akzo Nobel’s veterinary pharma business, announces that Malte Greune (41) has been appointed as a member of Intervet’s Executive Committee. Malte Greune will succeed Joost Helsen in the function ... |
| 4 October 2006 | Intervet appoints Ellen de Brabander as a member of the company’s Executive CommitteeIntervet, Akzo Nobel’s veterinary pharma business, announces that Ellen de Brabander – van den Berg (43) has been appointed as a member of Intervet’s Executive Committee, effective October 1, 2006. Ellen ... |
| 14 September 2006 | Intervet’s equine West Nile vaccine approved by USDAAn equine vaccine developed by Akzo Nobel’s animal health business Intervet, which is indicated for use in horses at risk from West Nile virus has been approved by the United States Department of Agriculture ... |
| 1 September 2006 | Intervet’s avian flu vaccine licensed for use in European UnionIntervet’s vaccine is based on a different strain (H5N2) than the current field strain (H5N1). Birds vaccinated with H5N2 form a different set of antibodies than those birds infected with H5N1. These ... |
| 21 August 2006 | Intervet Receives FDA Approval for ZilmaxIntervet’s U.S. business (Intervet Inc.) has received approval from the U.S. Food and Drug Administration (FDA) for Zilmax (zilpaterol hydrochloride), a product designed to improve production efficiencies ... |
| 27 July 2006 | Intervet continues to invest in Saxe Gotha business park in BoxmeerOn 27 July 2006, Intervet purchased the Plukon site at Saxe Gotha business park in Boxmeer. Covering over four hectares, the site is located opposite Intervet’s facilities. Thanks to this purchase, Intervet ... |
| 25 July 2006 | Citing Special Need, USDA Issues Conditional License for Poultry Industry’s First Vaccine for Necrotic EnteritisSchering-Plough Animal Health Now Field Testing Product in USSchering-Plough Animal Health Corporation has obtained a conditional license from the U.S. Department of Agriculture to begin field testing ... |
| 5 July 2006 | Foot-and-Mouth disease vaccine factory now owned by IntervetFive months after signing an agreement on sale and purchase the Foot-and-Mouth (FMD) vaccine factory in Cologne Bayer HealthCare AG and Intervet International bv have completed the acquisition. Both ... |
| 12 June 2006 | Intervet develops prototype for mass application avian influenza vaccineA biotech breakthrough achieved by Akzo Nobel’s animal health business, Intervet, means that mass application of a dual vaccine against avian influenza and Newcastle Disease could be available in the ... |
| 29 May 2006 | Intervet Dieter Lütticken Award - Intervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicinesIntervet International bv offers the Dieter Lütticken award to promote scientists or life science research institutions working in research areas that serve the 3R-concept i.e. reducing, refining or replacing ... |
| 27 April 2006 | Intervet supplies German zoos with avian influenza vaccineOn initiative of several federal states, Germany has obtained the European Union’s permission to vaccinate birds in zoos against avian influenza. To show its commitment to the preservation and protection ... |
| 29 March 2006 | Intervet supplies Avian Influenza vaccine from vaccine bank to government of IsraelOn Monday March 20, 2006 Intervet shipped 4 million doses of Nobilis Influenza (strain H5N2) into Israel out of its vaccine bank. After receipt of the emergency order the product has been shipped within ... |
| 14 March 2006 | FDA’s Approval of AQUAFLOR Marks New Era in TeamworkThe U.S. Food and Drug Administration’s recent approval of AQUAFLOR® (florfenicol) Type A Medicated Article for catfish marked a significant milestone in the industry’s combined efforts to make more products ... |
| 16 February 2006 | Intervet supplies Avian Influenza vaccine to French GovernmentYesterday the French Ministry of Agriculture announced the intention to vaccinate outdoor ducks against Avian Influenza in three western parts of France (Landes, Loire atlantique and Vendée). The French ... |
| 10 February 2006 | Intervet International bv acquires Foot and Mouth Disease vaccine factory from Bayer HealthCare AGBoxmeer, February 10, 2006 – Today, Intervet, the animal health business unit of Akzo Nobel, announced the agreement with Bayer HealthCare AG to acquire the Foot and Mouth Disease (FMD) vaccine factory ... |
| 1 February 2006 | Partnerships, Industry Cooperation Important in Source Verification Of U.S. CattleAnimal ID will challenge, redefine cattle industryVeterinarians and cattle producers and industry representatives said today that industry cooperation and partnerships will be critical in implementing ... |
| 27 January 2006 | Schering-Plough Animal Health Corporation Introduces New Product Application to Control Swine Respiratory DiseaseSchering-Plough Animal Health Corporation has introduced Nuflor® Oral 2.3% Concentrate Solution, the broadest spectrum oral antibiotic available for the treatment of several major causes of swine respiratory ... |
| 20 December 2005 | Millions to benefit from Intervet project in IndiaArnhem, the Netherlands, December 19, 2005 – Akzo Nobel’s animal healthcare business, Intervet, has signed a Memorandum of Understanding to exclusively supply veterinary products for a special project ... |
| 20 December 2005 | Schering-Plough Animal Health Launches New Web Site for AQUAFLOR® (florfenicol) in U.S.Schering-Plough Animal Health Corporation has launched a new web site to keep the U.S. aquaculture industry abreast of the latest developments with AQUAFLOR® (florfenicol), the first antibiotic approved ... |
| 30 November 2005 | Schering-Plough Animal Health Commemorates 50th AnniversaryCompany Recognizes Veterinarians with Donation to American Veterinary Medical FoundationSchering-Plough Animal Health Corp. (SPAH), a global leader in advancing the health and welfare of animals, is celebrating ... |
| 21 November 2005 | Intervet to support European ZoosBoxmeer, 21 November 2005 - In October the European Commission published a decision permitting the vaccination of zoo birds against bird flu, under certain conditions. The Dutch Government received EU ... |
| 11 November 2005 | Schering-Plough Receives First U.S. Approval for AQUAFLOR® (florfenicol)First In-Feed Antibiotic for U.S. Aquaculture in More Than 20 YearsSchering-Plough Corporation (NYSE: SGP) today announced its Animal Health Division has received approval from the U.S. Food and Drug ... |
| 22 September 2005 | Schering-Plough Animal Health Lends Aid and Support to People and Pets Affected by HurricaneKatrina Disaster Underscores Importance of Animal IdentificationSchering-Plough Animal Health Corp. (SPAH) today announced that it has contributed nearly $130,000 to aid Hurricane Katrina relief efforts ... |
| 22 August 2005 | Swiss scientist honored for excellent contribution to the principles of 3R'sAugust 22, 2005 – At the '5th World Congress on Alternatives', on 22 August in Berlin, Germany Prof. Andrew Hemphill, University of Bern, Switzerland was honored with the Intervet Dieter Lütticken Award ... |
| 9 August 2005 | Agreement reached for Intervet to acquire AgVax Developments Ltd, New ZealandBoxmeer, the Netherlands, and Hamilton, NZ, August 9, 2005 - Intervet aims to extend its market presence in New Zealand with the acquisition of AgVax Developments Ltd., a highly successful animal health ... |
| 25 July 2005 | Citing Special Need, USDA Issues Conditional License for Poultry Industry’s First Vaccine for Necrotic EnteritisSchering-Plough Animal Health Now Field Testing Product in USSchering-Plough Animal Health Corporation has obtained a conditional license from the U.S. Department of Agriculture to begin field testing ... |
| 7 June 2005 | Intervet to divest part of feed additives businessArnhem, the Netherlands, June 7, 2005 – Akzo Nobel’s animal healthcare business, Intervet, has agreed to divest some of its feed additives activities to Bulgarian company Biovet®. Both parties have agreed ... |
| 2 May 2005 | Announcement of new selection round Dieter Lütticken Award, Intervet’s annual award to reduce the number of animals used in testing for development and production of animal veterinary medicinesBoxmeer, May 2005 – For the second year Intervet International bv, the animal health business of Akzo Nobel, offer the Dieter Lütticken award to promote scientists or life science research institutions ... |
| 2 May 2005 | Announcement of winner Dieter Lütticken Award, new annual prize to reduce the number of testing animals in veterinary medicines awarded to Prof. Andrew Hemphill, SwitzerlandBoxmeer, May 2005 – For the first time Intervet International bv, the animal health business of Akzo Nobel, award an excellent contribution to the principle of 3Rs for the development and production ... |
| 4 February 2005 | Success through focus - Intervet sales releaseBoxmeer, February 4, 2005 - With net sales of EUR 1,024 million Intervet met its targets for 2004, consolidating its position as one of the world's three biggest animal health companies. Sales as reported ... |
| 21 June 2004 | Intervet India Commended For Its CommitmentBoxmeer, the Netherlands, June 18, 2004 – Last week, Intervet India received the Holland Award for its 'outstanding achievements in the field of International Agri-business in India and the Animal Health ... |
| 3 May 2004 | Feed Additives Business transferred to IntervetBoxmeer/Stenungsund, May 3, 2004 - In order to provide better market alignment and to strengthen Akzo Nobel’s overall position in feed additives, Akzo Nobel has decided to consolidate the CRINA® and Bredol ... |
| 19 February 2004 | Intervet maintains course despite economic headwindsBoxmeer, Netherlands, February 19, 2004 – With total sales in 2003 of EUR 1,010 million, Intervet is well positioned to maintain its No. 3 position in the global animal health market despite the economic ... |
| 2 February 2004 | Intervet provides support to authorities' efforts to halt the spread of bird flu in AsiaBoxmeer, the Netherlands, February 2, 2004 – Intervet, Akzo Nobel’s animal healthcare business, is providing local and international authorities support to combat the avian flu (Avian Influenza) epidemic ... |
| 8 December 2003 | All tools for emergency vaccination against Classical Swine Fever available after EU positively evaluates discriminatory antibody testBoxmeer, December 05, 2003 At the beginning of this month, the EU Standing Committee approved the EU Commission Decision on the positive evaluation of a discriminatory test for Classical Swine Fever (CSF). ... |
| 31 October 2003 | Nobilis Salenvac T vaccine receives award at VIV Europe 2003Boxmeer, October 19, 2003 - Nobilis Salenvac T, Intervet’s new vaccine that provides excellent protection for breeder and layer birds against Salmonella infections has received the VIV award in the category ... |
| 23 October 2003 | Salenvac T vaccine spreads wings at VIVBoxmeer, September 1, 2003 - VIV 2003 is the first non-UK debut of Nobilis Salenvac T, Intervet’s salmonella vaccine that protects against both S.enteritidis and S.typhimurium, making it an important ... |
| 11 April 2003 | Bommeli Diagnostics launches New CHEKIT-APP-AppIV TestLiebefeld-Bern, Switzerland -March 15, 2003- Bommeli Diagnostics, the diagnostic unit within Akzo Nobels veterinary business Intervet International bv today announced the launch of its new and improved ... |
| 1 April 2003 | Vaccination against Avian InfluenzaBoxmeer, March 27, 2003 - The outbreak of Avian Influenza (fowl plague) in the Netherlands has sparked an ongoing debate about vaccination as an additional measure to control this viral disease. In principle, ... |
| 13 March 2003 | Intervet weathered market challenges in 2002Boxmeer, March 07, 2003 – Intervet’s excellent global coverage and its broad range of products for farm and companion animals put the company in a stable position to weather the year’s dips in the veterinary ... |
| 11 March 2003 | Background information on Avian Influenza outbreakBoxmeer, March 11, 2003 – On March 1, 2003, the Dutch government decided to place a ban on all transport and export of poultry and poultry related farming products following a suspicion of an avian influenza ... |
